Autoantibodies against p16 protein-derived peptides may be a potential biomarker for non-small cell lung cancer

By Zhang Cong   Ye Leiguang   Guan Songlei   Jin Shunzi   Wang Weili   Sun Shilong   Lee Kuang-Hui   Wei Jun   Liu Baogang  

Tumor Biology, Vol. 35, Iss. 3, 2014-03 ,pp. : 2047-2051

Springer Publishing Company

Access to resources Recommend Favorite

Elevated Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor Binding Protein-2 in Malignant Pleural Effusion

By Olchovsky David   Shimon Ilan   Goldberg Iris   Shulimzon Tiberiu   Lubetsky Aharon   Yellin Alon   Pariente Clara   Karasik Avraham   Kanety Hannah  

Acta Oncologica, Vol. 41, Iss. 2, 2002-04 ,pp. : 182-187

Informa Healthcare

Access to resources Recommend Favorite

A pleiotropic effect of the single clustered hepatic metastamiRs miR-96-5p and miR-182-5p on insulin-like growth factor II, insulin-like growth factor-1 receptor and insulin-like growth factor-binding protein-3 in hepatocellular carcinoma

By          

Molecular Medicine Reports, Vol. 12, Iss. 1, 2015-01 ,pp. : 645-650

Spandidos Publications

Access to resources Recommend Favorite

Expression of insulin-like growth factor I receptor as a biomarker for predicting prognosis in biliary tract cancer patients

By                

Molecular and Clinical Oncology, Vol. 3, Iss. 3, 2015-01 ,pp. : 464-470

Science Publishers

Access to resources Recommend Favorite

Celecoxib inhibits insulin-like growth factor 1 induced growth and invasion in non-small cell lung cancer

By            

Oncology Letters, Vol. 5, Iss. 6, 2013-01 ,pp. : 1943-1947

Spandidos Publications

Access to resources Recommend Favorite